LEADING ARTICLE
Interleukin 12 and Th1 responses in inflammatory bowel disease
| The first 150 words of the full text of this article appear below. |
Immune phenomena are believed to play a key role in the
pathogenesis of tissue damage in Crohn's disease and ulcerative
colitis.1 2
Although some of the immunological
perturbations seem to be shared by Crohn's disease and ulcerative
colitis, there are important distinguishing features, possibly
reflecting different pathways of immune mediated intestinal
inflammation. Evidence indicates that macrophage and T cell derived
cytokines play a key role in the amplification and perpetuation of the
inflammatory response in both disorders.3 No aberrant
cytokine secretion has been documented in inflammatory bowel disease
(IBD) and no convincing evidence has as yet been provided that cytokine
changes occur as a result of disease specific immune activation.
However, a number of quantitative changes in the secretion and/or
activity of both proinflammatory and regulatory cytokines have been
reported in Crohn's disease and ulcerative colitis. Based on variation in the magnitude of these changes there seem to be different cytokine
This article has been cited by other articles:
-
Rovedatti, L, Kudo, T, Biancheri, P, Sarra, M, Knowles, C H, Rampton, D S, Corazza, G R, Monteleone, G, Di Sabatino, A, MacDonald, T T
(2009). Differential regulation of interleukin 17 and interferon {gamma} production in inflammatory bowel disease. Gut
58: 1629-1636
[Abstract] [Full Text] -
Dotan, I., Allez, M., Nakazawa, A., Brimnes, J., Schulder-Katz, M., Mayer, L.
(2007). Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-{gamma}. Am. J. Physiol. Gastrointest. Liver Physiol.
292: G1630-G1640
[Abstract] [Full Text] -
Foley, K. F., Pantano, C., Ciolino, A., Mawe, G. M.
(2007). IFN-{gamma} and TNF-{alpha} decrease serotonin transporter function and expression in Caco2 cells. Am. J. Physiol. Gastrointest. Liver Physiol.
292: G779-G784
[Abstract] [Full Text] -
Wada, Y., Lu, R., Zhou, D., Chu, J., Przewloka, T., Zhang, S., Li, L., Wu, Y., Qin, J., Balasubramanyam, V., Barsoum, J., Ono, M.
(2007). Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. Blood
109: 1156-1164
[Abstract] [Full Text] -
Gironella, M, Iovanna, J L, Sans, M, Gil, F, Penalva, M, Closa, D, Miquel, R, Pique, J M, Panes, J
(2005). Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut
54: 1244-1253
[Abstract] [Full Text] -
Akiho, H., Lovato, P., Deng, Y., Ceponis, P. J. M., Blennerhassett, P., Collins, S. M.
(2005). Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease. Am. J. Physiol. Gastrointest. Liver Physiol.
288: G609-G615
[Abstract] [Full Text] -
Radford-Smith, G L, Edwards, J E, Purdie, D M, Pandeya, N, Watson, M, Martin, N G, Green, A, Newman, B, Florin, T H J
(2002). Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut
51: 808-813
[Abstract] [Full Text] -
Monteleone, I, Vavassori, P, Biancone, L, Monteleone, G, Pallone, F
(2002). Immunoregulation in the gut: success and failures in human disease. Gut
50: iii60-64
[Abstract] [Full Text] -
DI SABATINO, A, CORAZZA, G R
(2001). Surviving too long in Crohn's disease. Gut
49: 6-8
[Full Text] -
Parrello, T., Monteleone, G., Cucchiara, S., Monteleone, I., Sebkova, L., Doldo, P., Luzza, F., Pallone, F.
(2000). Up-Regulation of the IL-12 Receptor {beta}2 Chain in Crohn's Disease. J. Immunol.
165: 7234-7239
[Abstract] [Full Text] -
Simmons, J D, Mullighan, C, Welsh, K I, Jewell, D P
(2000). Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut
47: 211-214
[Abstract] [Full Text] -
Caradonna, L., Amati, L., Magrone, T., Pellegrino, N.M., Jirillo, E., Caccavo, D.
(2000). Invited review: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. Innate Immunity
6: 205-214
[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
